Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 369

1.

Nitric Oxide-Dependent Protein Posttranslational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative Diseases.

Nakamura T, Lipton SA.

Antioxid Redox Signal. 2019 Oct 26. doi: 10.1089/ars.2019.7916. [Epub ahead of print]

PMID:
31657228
2.

NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model.

Okamoto SI, Prikhodko O, Pina-Crespo J, Adame A, McKercher SR, Brill LM, Nakanishi N, Oh CK, Nakamura T, Masliah E, Lipton SA.

Neurobiol Dis. 2019 Jul;127:390-397. doi: 10.1016/j.nbd.2019.03.029. Epub 2019 Mar 27.

PMID:
30928642
3.

Novel Direct Conversion of Microglia to Neurons.

Trudler D, Lipton SA.

Trends Mol Med. 2019 Feb;25(2):72-74. doi: 10.1016/j.molmed.2018.12.005. Epub 2019 Jan 2.

4.

The mouse as a model for neuropsychiatric drug development.

Howe JR 6th, Bear MF, Golshani P, Klann E, Lipton SA, Mucke L, Sahin M, Silva AJ.

Curr Biol. 2018 Sep 10;28(17):R909-R914. doi: 10.1016/j.cub.2018.07.046.

5.

Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease.

Mann AP, Scodeller P, Hussain S, Braun GB, Mölder T, Toome K, Ambasudhan R, Teesalu T, Lipton SA, Ruoslahti E.

Nat Commun. 2018 Mar 9;9(1):1070. doi: 10.1038/s41467-018-03517-0.

6.

Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein.

Ryan T, Bamm VV, Stykel MG, Coackley CL, Humphries KM, Jamieson-Williams R, Ambasudhan R, Mosser DD, Lipton SA, Harauz G, Ryan SD.

Nat Commun. 2018 Feb 26;9(1):817. doi: 10.1038/s41467-018-03241-9.

7.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G.

Cell Death Differ. 2018 Mar;25(3):486-541. doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23. Review.

8.

Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases.

Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, Bolaños JP, Culmsee C, Dawson VL, Deshmukh M, Duchen MR, Düssmann H, Fiskum G, Galindo MF, Hardingham GE, Hardwick JM, Jekabsons MB, Jonas EA, Jordán J, Lipton SA, Manfredi G, Mattson MP, McLaughlin B, Methner A, Murphy AN, Murphy MP, Nicholls DG, Polster BM, Pozzan T, Rizzuto R, Satrústegui J, Slack RS, Swanson RA, Swerdlow RH, Will Y, Ying Z, Joselin A, Gioran A, Moreira Pinho C, Watters O, Salvucci M, Llorente-Folch I, Park DS, Bano D, Ankarcrona M, Pizzo P, Prehn JHM.

Cell Death Differ. 2018 Mar;25(3):542-572. doi: 10.1038/s41418-017-0020-4. Epub 2017 Dec 11. Review.

9.

S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models.

Oh CK, Sultan A, Platzer J, Dolatabadi N, Soldner F, McClatchy DB, Diedrich JK, Yates JR 3rd, Ambasudhan R, Nakamura T, Jaenisch R, Lipton SA.

Cell Rep. 2017 Nov 21;21(8):2171-2182. doi: 10.1016/j.celrep.2017.10.068.

10.

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.

Tu S, Akhtar MW, Escorihuela RM, Amador-Arjona A, Swarup V, Parker J, Zaremba JD, Holland T, Bansal N, Holohan DR, Lopez K, Ryan SD, Chan SF, Yan L, Zhang X, Huang X, Sultan A, McKercher SR, Ambasudhan R, Xu H, Wang Y, Geschwind DH, Roberts AJ, Terskikh AV, Rissman RA, Masliah E, Lipton SA, Nakanishi N.

Nat Commun. 2017 Nov 14;8(1):1488. doi: 10.1038/s41467-017-01563-8.

11.

Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease.

Mann AP, Scodeller P, Hussain S, Braun GB, Mölder T, Toome K, Ambasudhan R, Teesalu T, Lipton SA, Ruoslahti E.

Nat Commun. 2017 Nov 10;8(1):1403. doi: 10.1038/s41467-017-01096-0. Erratum in: Nat Commun. 2018 Mar 9;9(1):1070.

12.

'SNO'-Storms Compromise Protein Activity and Mitochondrial Metabolism in Neurodegenerative Disorders.

Nakamura T, Lipton SA.

Trends Endocrinol Metab. 2017 Dec;28(12):879-892. doi: 10.1016/j.tem.2017.10.004. Epub 2017 Oct 30. Review.

13.

Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency.

Nagar S, Trudler D, McKercher SR, Piña-Crespo J, Nakanishi N, Okamoto SI, Lipton SA.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3741-3749. doi: 10.1167/iovs.17-21767.

14.

MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress.

Nagar S, Noveral SM, Trudler D, Lopez KM, McKercher SR, Han X, Yates JR 3rd, Piña-Crespo JC, Nakanishi N, Satoh T, Okamoto SI, Lipton SA.

Proc Natl Acad Sci U S A. 2017 May 16;114(20):E4048-E4056. doi: 10.1073/pnas.1613067114. Epub 2017 May 1.

15.

Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models.

Lipton SA, Rezaie T, Nutter A, Lopez KM, Parker J, Kosaka K, Satoh T, McKercher SR, Masliah E, Nakanishi N.

Cell Death Dis. 2016 Dec 1;7(12):e2499. doi: 10.1038/cddis.2016.389.

16.

Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons.

Sunico CR, Sultan A, Nakamura T, Dolatabadi N, Parker J, Shan B, Han X, Yates JR 3rd, Masliah E, Ambasudhan R, Nakanishi N, Lipton SA.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7564-E7571. Epub 2016 Nov 7.

17.

Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities.

Macrez R, Stys PK, Vivien D, Lipton SA, Docagne F.

Lancet Neurol. 2016 Sep;15(10):1089-102. doi: 10.1016/S1474-4422(16)30165-X. Epub 2016 Aug 8. Review.

PMID:
27571160
18.

Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling.

Singec I, Crain AM, Hou J, Tobe BTD, Talantova M, Winquist AA, Doctor KS, Choy J, Huang X, La Monaca E, Horn DM, Wolf DA, Lipton SA, Gutierrez GJ, Brill LM, Snyder EY.

Stem Cell Reports. 2016 Sep 13;7(3):527-542. doi: 10.1016/j.stemcr.2016.07.019. Epub 2016 Aug 25.

19.

S-Nitrosylation Induces Structural and Dynamical Changes in a Rhodanese Family Protein.

Eichmann C, Tzitzilonis C, Nakamura T, Kwiatkowski W, Maslennikov I, Choe S, Lipton SA, Riek R.

J Mol Biol. 2016 Sep 25;428(19):3737-51. doi: 10.1016/j.jmb.2016.07.010. Epub 2016 Jul 27.

20.

Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes.

Sanz-Blasco S, Piña-Crespo JC, Zhang X, McKercher SR, Lipton SA.

Neuroreport. 2016 Jun 15;27(9):705-9. doi: 10.1097/WNR.0000000000000601.

21.

Partnering with Big Pharma-What Academics Need to Know.

Lipton SA, Nordstedt C.

Cell. 2016 Apr 21;165(3):512-5. doi: 10.1016/j.cell.2016.04.021.

22.

Hydrogen Sulfide--Mechanisms of Toxicity and Development of an Antidote.

Jiang J, Chan A, Ali S, Saha A, Haushalter KJ, Lam WL, Glasheen M, Parker J, Brenner M, Mahon SB, Patel HH, Ambasudhan R, Lipton SA, Pilz RB, Boss GR.

Sci Rep. 2016 Feb 15;6:20831. doi: 10.1038/srep20831.

23.

Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease.

Takahashi H, Xia P, Cui J, Talantova M, Bodhinathan K, Li W, Saleem S, Holland EA, Tong G, Piña-Crespo J, Zhang D, Nakanishi N, Larrick JW, McKercher SR, Nakamura T, Wang Y, Lipton SA.

Sci Rep. 2016 Feb 12;6:20750. doi: 10.1038/srep20750. No abstract available.

24.

Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.

Akhtar MW, Sanz-Blasco S, Dolatabadi N, Parker J, Chon K, Lee MS, Soussou W, McKercher SR, Ambasudhan R, Nakamura T, Lipton SA.

Nat Commun. 2016 Jan 8;7:10242. doi: 10.1038/ncomms10242.

25.

Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.

Nakamura T, Lipton SA.

Trends Pharmacol Sci. 2016 Jan;37(1):73-84. doi: 10.1016/j.tips.2015.10.002. Epub 2015 Dec 17. Review.

26.

Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.

Chen S, Cui J, Jiang T, Olson ES, Cai QY, Yang M, Wu W, Guthrie JM, Robertson JD, Lipton SA, Ma L, Tsien RY, Gu Z.

J Cereb Blood Flow Metab. 2017 Jan;37(1):188-200. Epub 2015 Dec 17.

27.

Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease.

Takahashi H, Xia P, Cui J, Talantova M, Bodhinathan K, Li W, Saleem S, Holland EA, Tong G, Piña-Crespo J, Zhang D, Nakanishi N, Larrick JW, McKercher SR, Nakamura T, Wang Y, Lipton SA.

Sci Rep. 2015 Oct 19;5:14781. doi: 10.1038/srep14781. Erratum in: Sci Rep. 2016;6:20750. Saleem, Sofiyan [added].

28.

Regulation of the unfolded protein response via S-nitrosylation of sensors of endoplasmic reticulum stress.

Nakato R, Ohkubo Y, Konishi A, Shibata M, Kaneko Y, Iwawaki T, Nakamura T, Lipton SA, Uehara T.

Sci Rep. 2015 Oct 8;5:14812. doi: 10.1038/srep14812.

29.

Differential Effects of Pharmacologic and Genetic Modulation of NMDA Receptor Activity on HIV/gp120-Induced Neuronal Damage in an In Vivo Mouse Model.

Nakanishi N, Kang YJ, Tu S, McKercher SR, Masliah E, Lipton SA.

J Mol Neurosci. 2016 Jan;58(1):59-65. doi: 10.1007/s12031-015-0651-1. Epub 2015 Sep 15.

30.

Nrf2 and HSF-1 Pathway Activation via Hydroquinone-Based Proelectrophilic Small Molecules is Regulated by Electrochemical Oxidation Potential.

Satoh T, Stalder R, McKercher SR, Williamson RE, Roth GP, Lipton SA.

ASN Neuro. 2015 Aug 3;7(4). pii: 1759091415593294. doi: 10.1177/1759091415593294. Print 2015 Jul-Aug.

31.

Granulocyte-colony stimulating factor as a treatment for diabetic neuropathy in rat.

Kim KS, Song YS, Jin J, Joe JH, So BI, Park JY, Fang CH, Kim MJ, Cho YH, Hwang S, Ro YS, Kim H, Ahn YH, Sung HJ, Sung JJ, Park SH, Lipton SA.

Mol Cell Endocrinol. 2015 Oct 15;414:64-72. doi: 10.1016/j.mce.2015.07.014. Epub 2015 Jul 17.

PMID:
26190836
32.

Nitrosative Stress in the Nervous System: Guidelines for Designing Experimental Strategies to Study Protein S-Nitrosylation.

Nakamura T, Lipton SA.

Neurochem Res. 2016 Mar;41(3):510-4. doi: 10.1007/s11064-015-1640-z. Epub 2015 Jun 29. Review.

33.

The critical role of membralin in postnatal motor neuron survival and disease.

Yang B, Qu M, Wang R, Chatterton JE, Liu XB, Zhu B, Narisawa S, Millan JL, Nakanishi N, Swoboda K, Lipton SA, Zhang D.

Elife. 2015 May 15;4. doi: 10.7554/eLife.06500.

34.

Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.

Nakamura T, Prikhodko OA, Pirie E, Nagar S, Akhtar MW, Oh CK, McKercher SR, Ambasudhan R, Okamoto S, Lipton SA.

Neurobiol Dis. 2015 Dec;84:99-108. doi: 10.1016/j.nbd.2015.03.017. Epub 2015 Mar 18. Review.

35.

Protection from cyanide-induced brain injury by the Nrf2 transcriptional activator carnosic acid.

Zhang D, Lee B, Nutter A, Song P, Dolatabadi N, Parker J, Sanz-Blasco S, Newmeyer T, Ambasudhan R, McKercher SR, Masliah E, Lipton SA.

J Neurochem. 2015 Jun;133(6):898-908. doi: 10.1111/jnc.13074. Epub 2015 Mar 11.

36.

Zonarol, a sesquiterpene from the brown algae Dictyopteris undulata, provides neuroprotection by activating the Nrf2/ARE pathway.

Shimizu H, Koyama T, Yamada S, Lipton SA, Satoh T.

Biochem Biophys Res Commun. 2015 Feb 20;457(4):718-22. doi: 10.1016/j.bbrc.2015.01.059. Epub 2015 Jan 23.

37.

S-Nitrosylation in neurogenesis and neuronal development.

Okamoto S, Lipton SA.

Biochim Biophys Acta. 2015 Aug;1850(8):1588-93. doi: 10.1016/j.bbagen.2014.12.013. Epub 2014 Dec 18. Review.

38.

Transcriptional profiling of MEF2-regulated genes in human neural progenitor cells derived from embryonic stem cells.

Chan SF, Huang X, McKercher SR, Zaidi R, Okamoto SI, Nakanishi N, Lipton SA.

Genom Data. 2015 Mar 1;3:24-27.

39.

Stephen F. Heinemann: 1939-2014.

Lipton SA, Stevens CF.

Cell. 2014 Oct 9;159(2):231-2. No abstract available.

40.

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.

Tu S, Okamoto S, Lipton SA, Xu H.

Mol Neurodegener. 2014 Nov 14;9:48. doi: 10.1186/1750-1326-9-48. Review.

41.

Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models.

Choi MS, Nakamura T, Cho SJ, Han X, Holland EA, Qu J, Petsko GA, Yates JR 3rd, Liddington RC, Lipton SA.

J Neurosci. 2014 Nov 5;34(45):15123-31. doi: 10.1523/JNEUROSCI.4751-13.2014.

42.

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.

Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Campanella M, Candi E, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, Di Daniele N, Dixit VM, Dynlacht BD, El-Deiry WS, Fimia GM, Flavell RA, Fulda S, Garrido C, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Joseph B, Jost PJ, Kaufmann T, Kepp O, Klionsky DJ, Knight RA, Kumar S, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lugli E, Madeo F, Malorni W, Marine JC, Martin SJ, Martinou JC, Medema JP, Meier P, Melino S, Mizushima N, Moll U, Muñoz-Pinedo C, Nuñez G, Oberst A, Panaretakis T, Penninger JM, Peter ME, Piacentini M, Pinton P, Prehn JH, Puthalakath H, Rabinovich GA, Ravichandran KS, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Shi Y, Simon HU, Stockwell BR, Szabadkai G, Tait SW, Tang HL, Tavernarakis N, Tsujimoto Y, Vanden Berghe T, Vandenabeele P, Villunger A, Wagner EF, Walczak H, White E, Wood WG, Yuan J, Zakeri Z, Zhivotovsky B, Melino G, Kroemer G.

Cell Death Differ. 2015 Jan;22(1):58-73. doi: 10.1038/cdd.2014.137. Epub 2014 Sep 19. Review.

43.

S-nitrosylation-mediated redox transcriptional switch modulates neurogenesis and neuronal cell death.

Okamoto S, Nakamura T, Cieplak P, Chan SF, Kalashnikova E, Liao L, Saleem S, Han X, Clemente A, Nutter A, Sances S, Brechtel C, Haus D, Haun F, Sanz-Blasco S, Huang X, Li H, Zaremba JD, Cui J, Gu Z, Nikzad R, Harrop A, McKercher SR, Godzik A, Yates JR 3rd, Lipton SA.

Cell Rep. 2014 Jul 10;8(1):217-28. doi: 10.1016/j.celrep.2014.06.005. Epub 2014 Jul 4.

44.

Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells.

Ambasudhan R, Dolatabadi N, Nutter A, Masliah E, Mckercher SR, Lipton SA.

J Comp Neurol. 2014 Aug 15;522(12):2845-56. doi: 10.1002/cne.23617. Epub 2014 May 7. Review.

45.

Differential effects of synaptic and extrasynaptic NMDA receptors on Aβ-induced nitric oxide production in cerebrocortical neurons.

Molokanova E, Akhtar MW, Sanz-Blasco S, Tu S, Piña-Crespo JC, McKercher SR, Lipton SA.

J Neurosci. 2014 Apr 2;34(14):5023-8. doi: 10.1523/JNEUROSCI.2907-13.2014.

46.

ATM-dependent phosphorylation of MEF2D promotes neuronal survival after DNA damage.

Chan SF, Sances S, Brill LM, Okamoto S, Zaidi R, McKercher SR, Akhtar MW, Nakanishi N, Lipton SA.

J Neurosci. 2014 Mar 26;34(13):4640-53. doi: 10.1523/JNEUROSCI.2510-12.2014.

47.

Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells.

Zhu S, Ambasudhan R, Sun W, Kim HJ, Talantova M, Wang X, Zhang M, Zhang Y, Laurent T, Parker J, Kim HS, Zaremba JD, Saleem S, Sanz-Blasco S, Masliah E, McKercher SR, Cho YS, Lipton SA, Kim J, Ding S.

Cell Res. 2014 Jan;24(1):126-9. doi: 10.1038/cr.2013.156. Epub 2013 Dec 3. No abstract available.

48.

Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription.

Ryan SD, Dolatabadi N, Chan SF, Zhang X, Akhtar MW, Parker J, Soldner F, Sunico CR, Nagar S, Talantova M, Lee B, Lopez K, Nutter A, Shan B, Molokanova E, Zhang Y, Han X, Nakamura T, Masliah E, Yates JR 3rd, Nakanishi N, Andreyev AY, Okamoto S, Jaenisch R, Ambasudhan R, Lipton SA.

Cell. 2013 Dec 5;155(6):1351-64. doi: 10.1016/j.cell.2013.11.009. Epub 2013 Nov 27. Erratum in: Cell. 2013 Dec 19;155(7):1652-3.

49.

Reprint of: Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.

Satoh T, McKercher SR, Lipton SA.

Free Radic Biol Med. 2014 Jan;66:45-57. doi: 10.1016/j.freeradbiomed.2013.11.002. Epub 2013 Nov 18.

PMID:
24262357
50.

Potential effect of S-nitrosylated protein disulfide isomerase on mutant SOD1 aggregation and neuronal cell death in amyotrophic lateral sclerosis.

Jeon GS, Nakamura T, Lee JS, Choi WJ, Ahn SW, Lee KW, Sung JJ, Lipton SA.

Mol Neurobiol. 2014 Apr;49(2):796-807. doi: 10.1007/s12035-013-8562-z. Epub 2013 Oct 4.

Supplemental Content

Loading ...
Support Center